All Experts in Clinical Practice
Editors
Dr. Revital Shamri
Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel
Speakers
Dr. Nicolas Bazan
School of Medicine, Louisiana State University Health, New Orleans, USA
Prof. Martin Boeree
Radboud University Nijmegen Medical Centre TB Referral Hospital Dekkerswald, The Netherlands
Dr. Doug Brown
Victorian Spinal Cord Service, Austin Health, Australia
Prof. Daniel Carr
Tufts University School of Medicine and Javelin Pharmaceuticals, USA
Prof. Jack Cuzick
Wolfson Institute of Preventive Medicine, St. Bartholomew's Medical School, UK
Dr. Dennis Drayna
National Institute on Deafness and Other Communication Disorders, USA
Prof. Karen Duff
Columbia University Medical Center/NYS Psychiatric Institute, USA
Prof. Joe Duffy
St Vincent's University Hospital and University College Dublin, Ireland
Prof. Nick Fox
National Hospital for Neurology and Neurosurgery, Institute of Neurology, UCL, UK
Prof. Edward D. Hall
University of Kentucky College of Medicine, Spinal Cord & Brain Injury Research Center, USA
Prof. Ora Israel
Rambam Health Care Campus and Technion - Israel Institute of Technology, Israel
Prof. Carlos Kase
Boston University School of Medicine and Boston Medical Center, USA
Dr. Jarmo Kaukua
Obesity Research Unit, Helsinki University Central Hospital, Finland
Dr. Paul Kim
McMaster University and Thrombosis and Atherosclerosis Research Institute, Canada
Dr. Snejana Krassova
Independent Consultant (Former Head of Medical Affairs – Haematology, Bayer), Switzerland
Prof. David Livermore
Public Health England’s Antibiotic Resistance Monitoring and Reference Laboratory, UK
Prof. Don Mahuran
The Hospital for Sick Children and the University of Toronto, Canada
Prof. Ben J. Marais
Marie Bashir Institute for Infectious Diseases and Biosecurity (MBI) Centre for Research Excellence in Tuberculosis (TB-CRE) Clinical School, The Children’s Hospital at Westmead The University of Sydney
Prof. John Mayer
The School of Biomedical Sciences, University of Nottingham Medical School, UK
Dr. John McVey
MRC Clinical Sciences Centre, Imperial College London, UK
Prof. Oriol Mitjà
Fight Aids and Infectious Diseases Foundation, Hospital Germans Trias i Pujol, Barcelona,, Spain
Prof. John Oxford
St. Bartholomew’s, Royal London Hospital, Queen Mary’s School of Medicine and Dentistry, Retroscreen Virology Ltd., UK
Prof. Mark Pepys
UK NHS National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, UK
Prof. John Reinus
Montefiore Medical Center and Albert Einstein College of Medicine, USA
Dr. Rodolfo Rey
Centro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), Argentina
Prof. Arya Sharma
Michael G. deGroote School of Medicine, McMaster University, Canada
Dr. John Sims
Inflammation Research Group, Amgen Corp., Seattle, USA
Dr. Kasha Singh
University College London, UK and Monash University, Australia
Prof. Thomas Smith
Exposure, Epidemiology and Risk Program, Harvard School of Public Health
Prof. Boyd Swinburn
WHO Collaborating Center for Obesity Prevention, Deakin University, Australia
Dr. Baraa Tayeb
King Abdulaziz University Faculty of Medicine, Saudi Arabia
Prof. Neil Thomson
Institute of Infection, Immunity & Inflammation, University of Glasgow, UK
Dr. H. Rogier van Doorn
Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam
Dr. Richard Zaleskis
WHO Collaborating Centre for Research and Training in Management of Multidrug- Resistant Tuberculosis, Latvia
Dr. Ping Zhang
Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, USA